A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)

NCT05662332 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

795

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
T2D

Interventions

DRUG: Insulin Efsitora Alfa
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company